COLOPLAST A/S


Associated tags: Coloplast, Patient, Senior, Medicine

Locations: US, HUMLEBAEK, DK, NEW ROCHELLE, NEW YORK, NORTH AMERICA, UNITED STATES

Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US

Retrieved on: 
Wednesday, January 31, 2024

“Choosing the right dressing for wound treatment or pressure injury prevention should be simple and easy and give the patient a soft, secure and comfortable fit.

Key Points: 
  • “Choosing the right dressing for wound treatment or pressure injury prevention should be simple and easy and give the patient a soft, secure and comfortable fit.
  • Biatain Silicone Fit with 3DFit Technology is designed for both pressure injury prevention and wound management.
  • It stays securely in place during patient movement, fitting to body creases and allowing easy skin inspection as part of pressure injury prevention protocols3.
  • All sizes and shapes are developed and indicated for both pressure injury prevention and wound treatment to accommodate multiple purposes and a reduced number of SKUs.

Coloplast Launches New Catheter in the U.S.

Retrieved on: 
Friday, November 18, 2022

The new SpeediCath Flex Set with a no touch dry sleeve and an omni-directional tip is available as a catheter and bag solution, also called a Closed System.

Key Points: 
  • The new SpeediCath Flex Set with a no touch dry sleeve and an omni-directional tip is available as a catheter and bag solution, also called a Closed System.
  • With SpeediCath Flex Set, we are introducing an important solution for people living with SCI and many other health conditions.
  • Coloplast also offers additional support through its ColoplastCare program, which provides product and lifestyle advice, inspiration, and education resources for people living with bladder issues.
  • Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions.

Coloplast appoints new President of its global Interventional Urology business

Retrieved on: 
Tuesday, November 15, 2022

Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplasts global Interventional Urology (IU) business, replacing Steve Blum, who has decided to retire at the end of 2022.

Key Points: 
  • Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplasts global Interventional Urology (IU) business, replacing Steve Blum, who has decided to retire at the end of 2022.
  • He began his career with Coloplast in 2015 as Vice President and General Manager, Urology Care, North America, and was promoted the following year to Vice President of Global Marketing and Innovation, Interventional Urology.
  • "I am passionate about the work we do in Interventional Urology and I am excited to step into a new role.
  • Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice & Respiratory Care.

Coloplast launches Saffron™ Fixation System for Prolapse Repair

Retrieved on: 
Thursday, October 6, 2022

We want to invest in products that help surgeons treat women suffering from pelvic floor issues, and Saffron does just that, says Steve Blum, President of Interventional Urology at Coloplast.

Key Points: 
  • We want to invest in products that help surgeons treat women suffering from pelvic floor issues, and Saffron does just that, says Steve Blum, President of Interventional Urology at Coloplast.
  • The Saffron Fixation System is indicated for attaching sutures to ligaments of the pelvic floor.
  • The system allows for surgeons to use their choice of sutures and needles for POP repair and pairs ease of navigation with consistent, reliable anchor deployment for a secure fixation.
  • With Saffron, I can easily navigate through the surgical space to access the fixation site, and the unique curve enables perpendicular alignment on the ligament.

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

Retrieved on: 
Thursday, June 30, 2022

Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products.

Key Points: 
  • Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products.
  • This agreement is an important milestone in our journey to establish full access in the U.S. for Coloplast, the world's No.
  • By continuously gathering feedback from clinicians and patients, Coloplast is able to innovate and solve daily problems for ostomy care.
  • Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions.

New informational website around larynx cancer surgery

Retrieved on: 
Tuesday, May 17, 2022

The aim of the website is to provide reliableand easy access to information for anyone who will or has undergone a total laryngectomy, and their family and friends.

Key Points: 
  • The aim of the website is to provide reliableand easy access to information for anyone who will or has undergone a total laryngectomy, and their family and friends.
  • Receiving a diagnosis of laryngeal cancer with the recommendation that you undergo a total laryngectomy can cause distress and a difficult time for many.
  • The site contains inspirational and informational articles, videos, and downloadable assets addressing the frequently asked questions of patients and their supporters.
  • The structure is based upon the patients experience pre-surgery, in surgery, in the hospital, at home and living as a laryngectomee.

New randomized crossover study shows significant improvements in pulmonary symptoms for patients with total laryngectomy when switching to new product range

Retrieved on: 
Wednesday, March 23, 2022

The randomized cross-over clinical trial assessed the new Provox Life System for pulmonary rehabilitation and quality of life after total laryngectomy.

Key Points: 
  • The randomized cross-over clinical trial assessed the new Provox Life System for pulmonary rehabilitation and quality of life after total laryngectomy.
  • As a result of the patients improved state, anxiety and depression were also reduced.
  • Between December 2020 and April 2021, 40 laryngectomized patients in Italy who routinely used HMEs and adhesives were enrolled.
  • Improving pulmonary health and reducing the impact on the patients daily life has a positive effect on their quality of life.

Coloplast SenSura® Mio is Extended Wear in the US

Retrieved on: 
Tuesday, August 24, 2021

Coloplasts SenSura Mio ostomy system has been approved in the US for extended wear use, which represents the majority of the US ostomy barrier market2.

Key Points: 
  • Coloplasts SenSura Mio ostomy system has been approved in the US for extended wear use, which represents the majority of the US ostomy barrier market2.
  • Although the brand was initially launched into the standard wear category, new data shows SenSura Mio is a great option for those seeking an extended wear product, said Manu Varma, President and SVP of Chronic Care North America.
  • A recent survey of nearly 2,400 patients demonstrated that SenSura Mio reduces leakage while matching or outperforming the wear time of other extended wear products1.
  • Patients1, clinicians5, and lab-based data6 confirmed what we have suspected: SenSura Mio performs very well in the extended wear market, added Varma.

Coloplast to Donate $150,000 to Twin Cities Nonprofits Via New Community Engagement Program

Retrieved on: 
Monday, August 2, 2021

Coloplast announced today that between now and December 2022 it is awarding $150,000 in grants to nonprofits in the Twin Cities.

Key Points: 
  • Coloplast announced today that between now and December 2022 it is awarding $150,000 in grants to nonprofits in the Twin Cities.
  • Coloplast is committed to being an active and meaningful participant in our local community, said Manu Varma, President at Coloplast.
  • We recognize there is a critical need in the Twin Cities, especially among underserved and underrepresented members of our BIPOC communities.
  • The new community engagement program includes two components: a strategic, year-long partnership with one local Twin Cities nonprofit and a new community grant program.

Coloplast awarded Ostomy Products contract with Vizient

Retrieved on: 
Monday, March 29, 2021

Coloplast, a global medical device company and market leader in intimate healthcare, has been awarded a contract for ostomy products with Vizient, Inc ., the largest healthcare performance improvement company in the US.

Key Points: 
  • Coloplast, a global medical device company and market leader in intimate healthcare, has been awarded a contract for ostomy products with Vizient, Inc ., the largest healthcare performance improvement company in the US.
  • The new agreement allows Vizient members access with contracted pricing to Coloplasts full portfolio of ostomy products, including ostomy pouches and supporting products.
  • We are delighted that Vizient has added us to their Ostomy Products portfolio.
  • As part of the contract, SenSura Mio Baby & Kids, products developed by Coloplast for neonates, children and teenagers, will be included in Vizients Preferred Pediatric Program.